Results 171 to 180 of about 940,834 (307)

Regulation of phosphoinositide kinases in T cells. Evidence that phosphatidylinositol 3-kinase is not a substrate for T cell antigen receptor-regulated tyrosine kinases.

, 1992
Stephen G. Ward, Karin Reif, Steven C. Ley, Michael Fry, Michael D. Waterfield, Doreen A. Cantrell   +5 more
openalex   +1 more source

Current management of neurotrophic receptor tyrosine kinase fusion-positive sarcoma: an updated review. [PDF]

Jpn J Clin Oncol
Kubota Y, Kawano M, Iwasaki T, Itonaga I, Kaku N, Ozaki T, Tanaka K.   +6 more
europepmc   +1 more source

The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.

Cold Spring Harbor Perspectives in Biology, 2013
S. Hubbard
semanticscholar   +1 more source

Identification of in vivo brain-derived neurotrophic factor-stimulated autophosphorylation sites on the TrkB receptor tyrosine kinase by site-directed mutagenesis.

, 1994
Michelle Guiton, Frank J. Gunn‐Moore, Trevor N. Stitt, G.D. Yancopoulos, Jeremy M. Tavaré   +4 more
openalex   +1 more source

Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase. [PDF]

, 1990
James M. Trevillyan, Lu Yin, D. Atluru, C.A. Phillips, J M Bjorndahl   +4 more
openalex   +1 more source

Cellular Receptor Tyrosine Kinase Signaling Plays Important Roles in SARS-CoV-2 Infection. [PDF]

Pathogens
Sanchez S, Flannery BH, Murphy H, Huang Q, Ly H, Liang Y.   +5 more
europepmc   +1 more source

Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor.

, 1993
Terence F. McGuire, Seth J. Corey, Saı̈d Sebti   +2 more
openalex   +1 more source

Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). [PDF]

, 1991
Anna Mondino, Silvia Giordano, Paolo M. Comoglio   +2 more
openalex   +1 more source

A pharmacovigilance study of thromboembolism events associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors based on FAERS database. [PDF]

Sci Rep
Tang Z, Song H, Pan L, Zhang M, Li S, Li W, Chen W, Wang X.   +7 more
europepmc   +1 more source

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

Journal of Clinical Investigation, 2013
J. Schlegel, M. Sambade, S. Sather, S. Moschos, A. Tan, A. Winges, D. DeRyckere, Craig C. Carson, D. Trembath, J. Tentler, S. Eckhardt, Pei-Fen Kuan, R. Hamilton, L. Duncan, C. Miller, N. Nikolaishvili-Feinberg, B. Midkiff, Jing Liu, Weihe Zhang, Chao Yang, Xiaodong Wang, S. Frye, H. Earp, J. M. Shields, D. Graham   +24 more
semanticscholar   +1 more source